Pending final work on labeling and delivery of some preclinical pharmacokinetic data to the FDA, Alkermes Inc. and Cephalon Inc. have won marketing clearance for Vivitrol (formerly Vivitrex), their injectable drug against alcohol dependence. (BioWorld Today) Read More
